Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Valentina Giardini, Sara Allievi, Carla Fornari, Roberta Rovelli, Giancarlo Cesana, Alessandra Lafranconi & Patrizia Vergani. (2021) Management of pregnancy blood pressure increase in the emergency room: role of PlGF-based biochemical markers and relative economic impact. The Journal of Maternal-Fetal & Neonatal Medicine 34:7, pages 1083-1090.
Read now
Read now
Vijaya Sunder M & Nidhin R. Kunnath. (2020) Six Sigma to reduce claims processing errors in a healthcare payer firm. Production Planning & Control 31:6, pages 496-511.
Read now
Read now
Martin Hund, Wilma Verhagen-Kamerbeek, Manfred Reim, Diethelm Messinger, Reinhard van der Does & Holger Stepan. (2015) Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia – the PreOS study protocol. Hypertension in Pregnancy 34:1, pages 102-115.
Read now
Read now
Patrícia G. Teixeira, Zilma S. N. Reis, Silvia P. Andrade, Cézar A. Rezende, Eura M. Lage, Elizabeth P. Velloso, Carolina A. S. Santana & Antônio C. V. Cabral. (2013) Presymptomatic prediction of preeclampsia with angiogenic factors, in high risk pregnant women. Hypertension in Pregnancy 32:3, pages 312-320.
Read now
Read now
Nandini Hadker, Suchita Garg, Cory Costanzo, Wim van der Helm & James Creeden. (2013) Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective. Hypertension in Pregnancy 32:2, pages 105-119.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Zeynep Alpay Savasan, Juan Pedro Kusanovic, Giovanna Ogge, Eleazar Soto, Zhong Dong, Adi Tarca, Bhatti Gaurav & Sonia S. Hassan. (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 24:10, pages 1187-1207.
Read now
Read now
Articles from other publishers (43)
Jessica J Miller, Victoria Higgins, Nir Melamed, Michelle Hladunewich, Liyan Ma, Paul M Yip & Lei Fu. (2023) Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit. The Journal of Applied Laboratory Medicine 8:3, pages 457-468.
Crossref
Crossref
María José Rivera Mena, Andrés Felipe Mercado González, María del Cisne Vega Cobos & Gabriela Michelle Vanegas Contreras. (2023) Doppler de arterias uterinas para tamizaje y prevención de preeclampsia. Tesla Revista Científica 3:1, pages e119.
Crossref
Crossref
Max Hackelöer, Leon Schmidt & Stefan Verlohren. (2022) New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring. Archives of Gynecology and Obstetrics 308:6, pages 1663-1677.
Crossref
Crossref
Hongya Zhang, Xuexiang Li, Tianying Zhang, Qianhui Zhou & Cong Zhang. (2022) Establishment and validation of a predictive model of preeclampsia based on transcriptional signatures of 43 genes in decidua basalis and peripheral blood. BMC Bioinformatics 23:1.
Crossref
Crossref
Marianna Danielli, Roisin C. Thomas, Clare L. Gillies, Jiamiao Hu, Kamlesh Khunti & Bee Kang Tan. (2022) Blood biomarkers to predict the onset of pre-eclampsia: A systematic review and meta-analysis. Heliyon 8:11, pages e11226.
Crossref
Crossref
Sarah Heimberger, Joana Lopes Perdigao, Ariel Mueller, Gabriel Arenas, Melissa Kuriloff, Colleen Duncan, Courtney Amegashie & Sarosh Rana. (2022) Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia. Pregnancy Hypertension 28, pages 109-113.
Crossref
Crossref
Neily Zakiyah, Robin Tuytten, Philip N. Baker, Louise C. Kenny, Maarten J. Postma & Antoinette D. I. van Asselt. (2022) Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings. PLOS ONE 17:4, pages e0267313.
Crossref
Crossref
Frederic Chantraine, Kristel Van Calsteren, Roland Devlieger, Damien Gruson, Joachim Van Keirsbilck, Ana Dubon Garcia, Katleen Vandeweyer & Leonardo Gucciardo. (2021) Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers’ perspective. Pregnancy Hypertension 26, pages 31-37.
Crossref
Crossref
Liona C. Poon, Laura A. Magee, Stefan Verlohren, Andrew Shennan, Peter Dadelszen, Eyal Sheiner, Eran Hadar, Gerard Visser, Fabricio Da Silva Costa, Anil Kapur, Fionnuala McAuliffe, Amala Nazareth, Muna Tahlak, Anne B. Kihara, Hema Divakar, H. David McIntyre, Vincenzo Berghella, Huixia Yang, Roberto Romero, Kypros H. Nicolaides, Nir Melamed & Moshe Hod. (2021) A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia. International Journal of Gynecology & Obstetrics 154:S1, pages 3-31.
Crossref
Crossref
Anil Kapur & Moshe Hod. (2020) Maternal health and non‐communicable disease prevention: An investment case for the post COVID‐19 world and need for better health economic data. International Journal of Gynecology & Obstetrics 150:2, pages 151-158.
Crossref
Crossref
Silvi Shah. 2020. Obstetric and Gynecologic Nephrology. Obstetric and Gynecologic Nephrology
11
23
.
KE Duhig, PT Seed, JE Myers, R Bahl, G Bambridge, S Barnfield, J Ficquet, JC Girling, A Khalil, AH Shennan, LC Chappell & RM Hunter. (2019) Placental growth factor testing for suspected pre‐eclampsia: a cost‐effectiveness analysis. BJOG: An International Journal of Obstetrics & Gynaecology 126:11, pages 1390-1398.
Crossref
Crossref
Eyal Sheiner, Anil Kapur, Ravi Retnakaran, Eran Hadar, Liona C. Poon, H. David McIntyre, Hema Divakar, Anne Cathrine Staff, Jagat Narula, Anne B. Kihara, Moshe Hod, Mark Hanson, Mary D’Alton, Ronald Ma, Fionnuala McAuliffe, Carlos Fuchtner, CN Purandare, Gerard Visser, Jessica Morris & Rachel Gooden. (2019)
FIGO
(International Federation of Gynecology and Obstetrics) Postpregnancy Initiative: Long‐term Maternal Implications of Pregnancy Complications—Follow‐up Considerations
. International Journal of Gynecology & Obstetrics 147:S1, pages 1-31.
Crossref
Crossref
Dietmar Schlembach, Martin Hund, Cyrill Wolf & Manu Vatish. (2019) Diagnostic utility of angiogenic biomarkers in pregnant women with suspected preeclampsia: A health economics review. Pregnancy Hypertension 17, pages 28-35.
Crossref
Crossref
M.a José Alcaine Villarroya, Eva M. Barrenechea Iparraguirre, Elena Casals, Concepción González Rodríguez, Inmaculada Martín Navas, Hada Macher Manzano, M. Concepción Martínez Camarasa, Daniel Morell García, Helena Méndez Sol, Irene Rosas Allende, Elvira Tejedor Hernández & Belén Prieto García. (2019) Utilidad de los marcadores bioquímicos de preeclampsia. Revista del Laboratorio Clínico 12:3, pages e9-e24.
Crossref
Crossref
Elizabeth A. Phipps, Ravi Thadhani, Thomas Benzing & S. Ananth Karumanchi. (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology 15:5, pages 275-289.
Crossref
Crossref
D. Ortved, T. L.‐A. Hawkins, J.‐A. Johnson, J. Hyett & A. Metcalfe. (2019) Cost‐effectiveness of first‐trimester screening with early preventative use of aspirin in women at high risk of early‐onset pre‐eclampsia. Ultrasound in Obstetrics & Gynecology 53:2, pages 239-244.
Crossref
Crossref
Ignacio Herraiz García, Elisa Llurba Olive, Alberto Galindo Izquierdo & Stefan Verlohren. (2019) Actualización del diagnóstico y el pronóstico de la preeclampsia en embarazos únicos con la ayuda del cociente sFlt-1/PlGF. Progresos de Obstetricia y Ginecología.
Crossref
Crossref
Yuan Shen, Qiang Li, Xiaoning Liu, Shengbin Xiao & Hong Yan. (2019) Training and financial intervention for encouraging maternal health service utilization. Medicine 98:45, pages e17709.
Crossref
Crossref
Maria Portelli & Byron Baron. (2018) Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns. Journal of Pregnancy 2018, pages 1-23.
Crossref
Crossref
Christopher P Price, Jane Wolstenholme, Patrick McGinley & Andrew St John. (2017) Translational health economics: The key to accountable adoption of in vitro diagnostic technologies. Health Services Management Research 31:1, pages 43-50.
Crossref
Crossref
Kate Duhig, Brooke Vandermolen & Andrew Shennan. (2018) Recent advances in the diagnosis and management of pre-eclampsia. F1000Research 7, pages 242.
Crossref
Crossref
Linda J. E. Meertens, Hubertina C. J. Scheepers, Jessica P. M. M. Willemse, Marc E. A. Spaanderman & Luc J. M. Smits. (2018) Should women be advised to use calcium supplements during pregnancy? A decision analysis. Maternal & Child Nutrition 14:1, pages e12479.
Crossref
Crossref
Zoë M. McLaren, Alana Sharp, John P. Hessburg, Amir Sabet Sarvestani, Ethan Parker, James Akazili, Timothy R.B. Johnson & Kathleen H. Sienko. (2017) Cost effectiveness of medical devices to diagnose pre-eclampsia in low-resource settings. Development Engineering 2, pages 99-106.
Crossref
Crossref
Eliza F. Chakravarty & Virginia Steen. 2017. Scleroderma. Scleroderma
551
561
.
M. Vatish, T. Strunz‐McKendry, M. Hund, D. Allegranza, C. Wolf & C. Smare. (2016) sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK. Ultrasound in Obstetrics & Gynecology 48:6, pages 765-771.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Suzy Duckworth, Lucy C. Chappell, Paul T. Seed, Lucy Mackillop, Andrew H. Shennan & Rachael Hunter. (2016) Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks’ Gestation: A Budget Impact Analysis. PLOS ONE 11:10, pages e0164276.
Crossref
Crossref
Neily Zakiyah, Maarten J. Postma, Philip N. Baker & Antoinette D. I. van Asselt. (2015) Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments. PharmacoEconomics 33:10, pages 1069-1082.
Crossref
Crossref
Ulrik Dolberg Anderson, Magnus Gram, Bo Åkerström & Stefan R. Hansson. (2015) First Trimester Prediction of Preeclampsia. Current Hypertension Reports 17:9.
Crossref
Crossref
Di Jia, Roopali Roy & Marsha A. Moses. 2015. Matrix Metalloproteinase Biology. Matrix Metalloproteinase Biology
183
214
.
Cindy M. Anderson, Jody L. Ralph, Michelle L. Wright, Bryan Linggi & Joyce E. Ohm. (2013) DNA Methylation as a Biomarker for Preeclampsia. Biological Research For Nursing 16:4, pages 409-420.
Crossref
Crossref
Lucy C Chappell, Kate Bramham & Andrew H Shennan. (2014) Short-term prediction of preeclampsia: how close are we?. Biomarkers in Medicine 8:4, pages 455-458.
Crossref
Crossref
Melanie Griffin & Andrew H Shennan. (2014) Clinical applications of biomarkers in preeclampsia. Biomarkers in Medicine 8:4, pages 459-470.
Crossref
Crossref
Lucy C. ChappellSuzy DuckworthPaul T. SeedMelanie GriffinJenny MyersLucy MackillopNigel SimpsonJason WaughDilly AnumbaLouise C. KennyChristopher W.G. RedmanAndrew H. Shennan. (2013) Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia. Circulation 128:19, pages 2121-2131.
Crossref
Crossref
C Hyde & S Thornton. (2013) Does screening for pre-eclampsia make sense?. BJOG: An International Journal of Obstetrics & Gynaecology 120:10, pages 1168-1170.
Crossref
Crossref
WT Schnettler, D Dukhovny, J Wenger, S Salahuddin, SJ Ralston & S Rana. (2013) Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology 120:10, pages 1224-1232.
Crossref
Crossref
Damien Gruson, Clemence Djuidjé Yuemo, Jean-François Classen, Thibault Lepoutre, Nicolas Piquard & Frederic Debiève. (2013) First trimester placental growth factor and soluble fms-like tyrosine kinase 1 are significantly related to PAPP-A levels. Clinical Chemistry and Laboratory Medicine (CCLM) 51:4, pages e49-e51.
Crossref
Crossref
Vikram Sinai Talaulikar & Hassan Shehata. (2012) Uric acid: is it time to give up routine testing in management of pre-eclampsia?. Obstetric Medicine 5:3, pages 119-123.
Crossref
Crossref
Reem Mustafa, Sana Ahmed, Anu Gupta & Rocco C. Venuto. (2012) A Comprehensive Review of Hypertension in Pregnancy. Journal of Pregnancy 2012, pages 1-19.
Crossref
Crossref
Stefan Verlohren, Holger Stepan & Ralf Dechend. (2011) Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clinical Science 122:2, pages 43-52.
Crossref
Crossref
Virginia Steen & Eliza F. Chakravarty. 2012. Scleroderma. Scleroderma
547
557
.
Amir Shmueli, Hamutal Meiri & Ron Gonen. (2012) Economic assessment of screening for pre‐eclampsia. Prenatal Diagnosis 32:1, pages 29-38.
Crossref
Crossref